About: "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunode

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunode Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunode (en)
skos:prefLabel	"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunode (en)
name	"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunode (en)
title	wds:Q63321027-3BA73E29-7F89-4383-91BF-7AADAC26FFBC
title	Randomised, Multicentric, Phase ii Study of the Immunogenicity of a "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency (en)
end time	wds:Q63321027-3F3D096C-88A0-4436-A17D-9E66CDCACB27
end time	2013-03-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q63321027-683B9E78-0FF5-4D6A-8348-7B710CB01A4D
instance of	clinical trial
start time	wds:Q63321027-A81AD81A-BA59-4AF4-97ED-FC9846EE0715
start time	2009-06-01 00:00:00Z (xsd:dateTime)
country	wds:Q63321027-01E48EA8-414B-4C01-8EBA-3FB0C685E0E6
country	France
short name	wds:Q63321027-594B6133-4FA4-4E18-8167-031E99D44A07
short name	EVAD (en)
research intervention	wds:Q63321027-1CBF06D7-379C-4DC0-BE5F-48F94A52DF3F
research intervention	heptavalent pneumococcal conjugate vaccine
minimum age	wds:Q63321027-8DA295D0-5044-4923-996D-1B6EE29488BF
minimum age	18 (xsd:decimal)
medical condition	wds:Q63321027-A9267DCC-B462-458A-8F1B-1B6546E8FD40
medical condition	common variable immunodeficiency
number of participants	wds:Q63321027-8A5A599B-6C61-4BBC-93A4-7E378CE2CCD2
number of participants	45 (xsd:decimal)
maximum age	wds:Q63321027-E0200124-9E68-4158-A1AB-1F43F0B48FAF
maximum age	65 (xsd:decimal)
study type	wds:Q63321027-F41E5234-A1CC-470F-BE5E-B8F48E94D885
study type	interventional study
ClinicalTrials.gov ID	wds:Q63321027-C26FEF2C-4392-494C-915C-AB39F93AD011
ClinicalTrials.gov ID	NCT01489618
clinical trial phase	wds:Q63321027-9C9C912A-1C97-4C25-BB3B-283FB80D635F
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63321027

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software